• Consensus Rating: Buy
  • Consensus Price Target: $61.33
  • Forecasted Upside: 57.83 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$38.86
▼ -2.5 (-6.04%)

This chart shows the closing price for CYRX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cryoport Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CYRX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CYRX

Analyst Price Target is $61.33
▲ +57.83% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Cryoport in the last 3 months. The average price target is $61.33, with a high forecast of $92.00 and a low forecast of $42.00. The average price target represents a 57.83% upside from the last price of $38.86.

This chart shows the closing price for CYRX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 6 polled investment analysts is to buy stock in Cryoport. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/25/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/26/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/24/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/22/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/20/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/21/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/20/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/12/2022Needham & Company LLCBoost TargetBuy$41.00 ➝ $42.00N/A
6/17/2022Needham & Company LLCReiterated RatingBuy$41.00Low
5/17/2022B. RileyLower Target$61.00 ➝ $55.00Low
5/6/2022BTIG ResearchLower Target$95.00 ➝ $60.00Medium
5/6/2022KeyCorpLower Target$92.00 ➝ $52.00Medium
5/3/2022Roth CapitalLower Target$90.00 ➝ $67.00High
4/13/2022Needham & Company LLCReiterated RatingBuy$45.00Low
3/2/2022B. RileyLower Target$94.00 ➝ $70.00Low
2/25/2022SVB LeerinkBoost TargetOutperform$75.00 ➝ $92.00High
2/25/2022Needham & Company LLCLower TargetBuy$93.00 ➝ $45.00High
1/19/2022Roth CapitalUpgradeNeutral ➝ Buy$90.00High
11/11/2021B. RileyReiterated RatingBuyMedium
11/5/2021Roth CapitalDowngradeBuy ➝ Neutral$78.00 ➝ $90.00High
11/5/2021Needham & Company LLCBoost TargetBuy$79.00 ➝ $93.00High
11/5/2021KeyCorpBoost TargetOverweight$75.00 ➝ $92.00High
10/26/2021BTIG ResearchBoost TargetPositive ➝ Buy$80.00 ➝ $95.00Low
10/19/2021B. RileyReiterated RatingBuyHigh
8/6/2021Roth CapitalBoost TargetBuy$72.00 ➝ $78.00High
8/6/2021Needham & Company LLCBoost TargetBuy$77.00 ➝ $79.00High
7/16/2021BTIG ResearchInitiated CoverageBuy$80.00Low
5/5/2021Needham & Company LLCBoost TargetBuy$73.00 ➝ $77.00High
3/15/2021UBS GroupInitiated CoverageBuy$84.00Medium
3/2/2021SVB LeerinkBoost TargetOutperform$50.00 ➝ $75.00High
3/2/2021Needham & Company LLCReiterated RatingBuy$73.00High
2/10/2021B. RileyBoost TargetBuy$69.00 ➝ $81.00Low
1/19/2021KeyCorpBoost TargetOverweight$54.00 ➝ $75.00Low
1/14/2021Roth CapitalBoost TargetBuy$60.00 ➝ $72.00High
1/12/2021B. RileyBoost TargetBuy$66.00 ➝ $69.00Medium
11/9/2020KeyCorpInitiated CoverageOverweight$54.00High
11/6/2020Needham & Company LLCBoost TargetBuy$44.00 ➝ $45.00High
9/10/2020B. RileyBoost Target$45.00 ➝ $66.00Medium
8/24/2020Roth CapitalBoost TargetBuy$42.00 ➝ $50.00High
8/24/2020Needham & Company LLCBoost TargetBuy$37.00 ➝ $44.00High
8/24/2020StephensBoost TargetOverweight$38.00 ➝ $44.00High
8/7/2020Needham & Company LLCBoost TargetBuy$23.00 ➝ $37.00High
7/21/2020SVB LeerinkReiterated RatingOutperformMedium
7/7/2020B. RileyBoost Target$24.00 ➝ $40.00Low
5/11/2020Roth CapitalBoost Target$25.00 ➝ $30.00Medium
5/8/2020SVB LeerinkBoost TargetOutperform$24.00 ➝ $25.00High
4/7/2020B. RileyReiterated RatingBuy$24.00High
3/26/2020Needham & Company LLCReiterated RatingBuy$23.00Low
3/6/2020Janney Montgomery ScottReiterated RatingBuy$25.00 ➝ $25.00Medium
3/6/2020Needham & Company LLCBoost TargetBuy$22.00 ➝ $23.00High
2/13/2020B. RileyLower TargetBuy$26.00 ➝ $24.00Medium
1/13/2020Needham & Company LLCLower TargetBuy$24.00 ➝ $22.00High
1/10/2020B. RileyInitiated CoverageBuy$26.00High
1/7/2020StephensInitiated CoverageOverweight$21.00High
7/19/2019B. RileySet TargetBuy$26.00N/A
7/15/2019SVB LeerinkReiterated RatingOutperformLow
7/1/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$22.00Medium
10/10/2018B. RileyInitiated CoverageBuy ➝ Buy$22.00Medium
8/13/2018CowenBoost TargetOutperform ➝ Outperform$11.00 ➝ $16.00High
7/2/2018Needham & Company LLCBoost TargetBuy$11.00 ➝ $19.00High
6/29/2018Roth CapitalBoost TargetBuy$12.50 ➝ $22.00Medium
3/8/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$10.00 ➝ $11.00Medium
11/30/2017Roth CapitalInitiated CoverageBuy ➝ Buy$12.50High
10/3/2017Janney Montgomery ScottBoost TargetBuy$10.00 ➝ $12.00Low
9/12/2017CowenReiterated RatingOutperform ➝ Outperform$7.50 ➝ $11.00Low
8/30/2017Needham & Company LLCBoost TargetBuy ➝ Buy$8.50 ➝ $10.00High
(Data available from 8/19/2017 forward)

News Sentiment Rating

0.23 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/21/2022
  • 3 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
2/20/2022
  • 3 very positive mentions
  • 11 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
3/22/2022
  • 2 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/21/2022
  • 2 very positive mentions
  • 11 positive mentions
  • 7 negative mentions
  • 0 very negative mentions
5/21/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/20/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/20/2022
  • 3 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
8/19/2022

Current Sentiment

  • 3 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
Cryoport logo
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
Read More

Today's Range

Now: $38.86
Low: $38.73
High: $40.90

50 Day Range

MA: $34.50
Low: $24.08
High: $45.01

52 Week Range

Now: $38.86
Low: $19.82
High: $86.30

Volume

306,380 shs

Average Volume

515,656 shs

Market Capitalization

$1.88 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13

Frequently Asked Questions

What sell-side analysts currently cover shares of Cryoport?

The following Wall Street sell-side analysts have issued research reports on Cryoport in the last twelve months: B. Riley, BTIG Research, KeyCorp, Needham & Company LLC, Roth Capital, SVB Leerink LLC, and TheStreet.
View the latest analyst ratings for CYRX.

What is the current price target for Cryoport?

6 Wall Street analysts have set twelve-month price targets for Cryoport in the last year. Their average twelve-month price target is $61.33, suggesting a possible upside of 57.8%. SVB Leerink LLC has the highest price target set, predicting CYRX will reach $92.00 in the next twelve months. Needham & Company LLC has the lowest price target set, forecasting a price of $42.00 for Cryoport in the next year.
View the latest price targets for CYRX.

What is the current consensus analyst rating for Cryoport?

Cryoport currently has 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CYRX will outperform the market and that investors should add to their positions of Cryoport.
View the latest ratings for CYRX.

What other companies compete with Cryoport?

How do I contact Cryoport's investor relations team?

Cryoport's physical mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The consumer goods maker's listed phone number is (949) 470-2300 and its investor relations email address is [email protected] The official website for Cryoport is www.cryoport.com. Learn More about contacing Cryoport investor relations.